|
Jul 27
|
3 Asian Stocks Estimated To Be Up To 48.5% Below Intrinsic Value
|
|
Jun 19
|
Simcere Zaiming Announces First Patient Dosed in the US in a Phase 1 Trial of Trispecific Antibody SIM0500 in Patients with Relapsed/Refractory Multiple Myeloma
|
|
Jun 16
|
NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6
|